Terms: = Colorectal cancer AND PPFIBP1, L2, 8496, ENSG00000110841, hSGT2, hSgt2p AND Prognosis
16 results:
1. Identification and Validation of the Glycolysis and Immune-related Gene Signature for prognosis in colorectal cancer.
Jiang M; Liu Y; Xu J; Xu Z; Ye T; Li S; Jiang C
Anticancer Res; 2024 Jan; 44(1):117-131. PubMed ID: 38159970
[TBL] [Abstract] [Full Text] [Related]
2. Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment.
Hoshimoto A; Tatsuguchi A; Hamakubo R; Nishimoto T; Omori J; Akimoto N; Tanaka S; Fujimori S; Hatori T; Shimizu A; Iwakiri K
World J Gastroenterol; 2023 Oct; 29(40):5566-5581. PubMed ID: 37970475
[TBL] [Abstract] [Full Text] [Related]
3. Cholinergic signaling influences the expression of immune checkpoint inhibitors, PD-L1 and PD-L2, and tumor hallmarks in human colorectal cancer tissues and cell lines.
Kuol N; Godlewski J; Kmiec Z; Vogrin S; Fraser S; Apostolopoulos V; Nurgali K
BMC Cancer; 2023 Oct; 23(1):971. PubMed ID: 37828429
[TBL] [Abstract] [Full Text] [Related]
4. High MICAL-L2 expression and its role in the prognosis of colon adenocarcinoma.
Yang Y; Ye F; Xia T; Wang Q; Zhang Y; Du J
BMC Cancer; 2022 May; 22(1):487. PubMed ID: 35501725
[TBL] [Abstract] [Full Text] [Related]
5. Contribution of endothelial cell-derived transcriptomes to the colon cancer based on bioinformatics analysis.
Wang J; Uddin MN; Akter R; Wu Y
Math Biosci Eng; 2021 Aug; 18(6):7280-7300. PubMed ID: 34814249
[TBL] [Abstract] [Full Text] [Related]
6. PD-1 and PD-L2 expression predict relapse risk and poor survival in patients with stage III colorectal cancer.
Zengin M; Zergeroğlu S; Okcu O; Benek S
Cell Oncol (Dordr); 2021 Apr; 44(2):423-432. PubMed ID: 33469839
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic and clinicopathological utility of PD-L2 expression in patients with digestive system cancers: A meta-analysis.
Lin X; Lin K; Lin C; Wang J; Tang Y
Int Immunopharmacol; 2020 Nov; 88():106946. PubMed ID: 33182023
[TBL] [Abstract] [Full Text] [Related]
8. A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic colorectal cancer.
Floudas CS; Brar G; Mabry-Hrones D; Duffy AG; Wood B; Levy E; Krishnasamy V; Fioravanti S; Bonilla CM; Walker M; Morelli MP; Kleiner DE; Steinberg SM; Figg WD; Greten TF; Xie C
Clin Colorectal Cancer; 2019 Dec; 18(4):e349-e360. PubMed ID: 31351862
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological significance and prognostic implication of programmed death-1 ligand 2 expression in colorectal cancer.
Pyo JS; Son BK; Chung KH; Oh IH
Int J Biol Markers; 2019 Sep; 34(3):276-283. PubMed ID: 31337259
[TBL] [Abstract] [Full Text] [Related]
10. Polymorphism of the programmed death-ligand 1 gene is associated with its protein expression and prognosis in gastric cancer.
Wu Y; Zhao T; Jia Z; Cao D; Cao X; Pan Y; Zhao D; Zhang B; Jiang J
J Gastroenterol Hepatol; 2019 Jul; 34(7):1201-1207. PubMed ID: 30353572
[TBL] [Abstract] [Full Text] [Related]
11. The importance of mitochondrial folate enzymes in human colorectal cancer.
Miyo M; Konno M; Colvin H; Nishida N; Koseki J; Kawamoto K; Tsunekuni K; Nishimura J; Hata T; Takemasa I; Mizushima T; Doki Y; Mori M; Ishii H
Oncol Rep; 2017 Jan; 37(1):417-425. PubMed ID: 27878282
[TBL] [Abstract] [Full Text] [Related]
12. Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors.
Danilova L; Wang H; Sunshine J; Kaunitz GJ; Cottrell TR; Xu H; Esandrio J; Anders RA; Cope L; Pardoll DM; Drake CG; Taube JM
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):E7769-E7777. PubMed ID: 27837027
[TBL] [Abstract] [Full Text] [Related]
13. Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer.
Barrett MT; Anderson KS; Lenkiewicz E; Andreozzi M; Cunliffe HE; Klassen CL; Dueck AC; McCullough AE; Reddy SK; Ramanathan RK; Northfelt DW; Pockaj BA
Oncotarget; 2015 Sep; 6(28):26483-93. PubMed ID: 26317899
[TBL] [Abstract] [Full Text] [Related]
14. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.
Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB
Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200
[TBL] [Abstract] [Full Text] [Related]
15. Laser pressure catapulting (LPC): optimization LPC-system and genotyping of colorectal carcinomas.
Bazan V; La Rocca G; Corsale S; Agnese V; Macaluso M; Migliavacca M; Gregorio V; Cascio S; Sisto PS; Di Fede G; Buscemi M; Fiorentino E; Passantino R; Morello V; Tomasino RM; Russo A
J Cell Physiol; 2005 Feb; 202(2):503-9. PubMed ID: 15316933
[TBL] [Abstract] [Full Text] [Related]
16. [Successful induction chemotherapy after colectomy in a case of acute lymphoblastic leukemia associated with obstructive ileus caused by sigmoid colon carcinoma].
Shimamoto T; Ohyashiki J; Utsumi K; Ohyashiki K; Toyama K
Rinsho Ketsueki; 1990 Feb; 31(2):249-53. PubMed ID: 2329688
[TBL] [Abstract] [Full Text] [Related]
